Skip to main content

Table 3 Results of quality of life assessments, bleeding and pain scores and procedure acceptability

From: A patient-preference cohort study of office versus inpatient uterine polyp treatment for abnormal uterine bleeding

 

Office polypectomy

Inpatient polypectomy

  

Mean (SD, n)

Mean (SD, n)

Difference (95 % CI)a, p value

Adjusted differenceh (95 % CI), p value

MMASb

 

 Baseline

63 (26, 163)

61 (28, 37)

  

 6 months

77 (25, 135)g

79 (25, 25)g

−3 (−12, 7), p = 0.55

−4 (−14, 3), p = 0.18

EuroQol EQ-5Dc

 

 Baseline

0.79 (0.26, 312)

0.72 (0.30, 71)

  

 6 months

0.82 (0.25, 289)g

0.81 (0.30, 56)

0.00 (−0.07, 0.06), p = 0.88

0.01 (−0.05, 0.08), p = 0.64

EuroQol health thermometerd

 

 Baseline

78 (18, 305)

75 (21, 71)

  

 6 months

78 (19, 291)

79 (20, 57)

−2 (−7, 3), p = 0.34

−1 (−4, 5), p = 0.81

Bleeding duration visual analogue scalee

 

 Baseline

39 (26, 74)

38 (26, 23)

  

 6 months

30 (28, 65)g

18 (19, 16)g

−13 (−27, 2), p = 0.09

−13 (−27, 2), p = 0.09

Bleeding amount visual analogue scalef

 

 Baseline

59 (28, 75)

58 (26, 23)

  

 6 months

32 (28, 68)g

26 (27, 16)g

−4 (−19, 11), p = 0.61

−3 (−20, 14), p = 0.72

Operation pain scores

    

 During procedurei

42 (26, 296)

 60 min after procedurei

27 (24, 247)

20 (24, 60)

−7 (−14, 0), p = 0.04

−8 (−11, −4), p = 0.03

 On dischargei

22 (21, 276)

13 (18, 57)

−9 (−15, −3), p = 0.003

−9 (−15, −3), p = 0.002

 

n (%)

n (%)

OR (95 % CI), p valuej

Adjusted ORh (95 % CI), p value

Operation acceptability

    

 Totally

194 (65 %)

52 (81 %)

  

 Generally

48 (16 %)

9 (14 %)

0.21 (0.06, 0.69), p = 0.01k

0.19 (0.05, 0.70), p = 0.01k

 Fairly

50 (17 %)

3 (5%)

  

 Unacceptable

7 (2 %)

0 (–)

  

Exposure embarrassing?

    

 Extremely

5 (2 %)

2 (3 %)

  

 Moderately

30 (10 %)

7 (12 %)

1.4 (0.6, 3.0), p = 0.46l

1.4 (0.6, 3.7), p = 0.36l

 A little

90 (30 %)

8 (13 %)

  

 No

177 (59 %)

43 (72 %)

  

Recommend to a friend?

    

 Yes/total

282/302 (93 %)

62/64 (97 %)

0.45 (0.10, 2.0), p = 0.28

Not possible to compute

Same treatment again?

    

 Yes/total

283/300 (94 %)

62/63 (98 %)

0.27 (0.04, 2.1), p = 0.21

Not possible to compute

Preferred alternative treatment?

   

 Yes/total

36/299 (12 %)

10/63 (16 %)

1.4 (0.7, 3.0), p = 0.41

1.5 (0.7, 3.5), p = 0.32

  1. n number of responses
  2. aDifference between groups at each time point adjusted for baseline score. Estimates of differences >0 favour office polypectomy, those <0 favour inpatient polypectomy
  3. bMenorrhagia Multi-Attribute Scale questionnaire. Scores range from 0 (severely affected) to 100 (not affected). Restricted to those with heavy menstrual and intermenstrual bleeding only
  4. cHealth-related quality of life questionnaire. Scores range from −0.59 (health state worse than death) to 1.0 (perfect health state)
  5. dHealth-related quality of life questionnaire. Scores range 0 (worst imaginable health state) to 1.0 (best imaginable health state)
  6. eVisual Analogue Scale score. Scores range from 0 (no days of bleeding in the last month) to 100 (bleeding every day in the last month). Restricted to those with heavy menstrual bleeding only
  7. fVisual Analogue Scale score. Scores range from 0 (no bleeding in the last month) to 100 (heaviest imaginable bleeding in the last month). Restricted to those with heavy menstrual bleeding only
  8. g p < 0.05 when compared with baseline score within group (by paired t test)
  9. hSee statistical methods section for details on adjustments
  10. iVisual Analogue Scale score. Scores range from 0 (no pain at all) to 100 (worst imaginable pain). T test used for analysis
  11. jEstimates of OR > 1 favour office polypectomy, those <1 favour inpatient polypectomy
  12. kTotally acceptable/generally acceptable vs. fairly acceptable/unacceptable combined categories used to calculate odds ratio
  13. lExtremely/moderately vs. a little/no combined categories used to calculate odds ratio